LEF-1 immunohistochemistry, a better diagnostic biomarker than β-catenin for medulloblastoma, WNT-activated subtyping

J Neuropathol Exp Neurol. 2024 Jan 19;83(2):136-138. doi: 10.1093/jnen/nlad104.
No abstract available

Publication types

  • Letter

MeSH terms

  • Biomarkers
  • Cerebellar Neoplasms* / diagnosis
  • Humans
  • Immunohistochemistry
  • Medulloblastoma* / diagnosis
  • beta Catenin

Substances

  • beta Catenin
  • Biomarkers